Related Experiment Video
Updated: Jul 18, 2026

High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Therapeutic options for sleep-maintenance and sleep-onset insomnia
Anna K Morin1, Courtney I Jarvis, Ann M Lynch
1Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Worcester, Massachusetts 01608-1715, USA. anna.morin@mcphs.edu
Insomnia treatments range from non-drug therapies like cognitive behavioral therapy to medications such as ramelteon. Clinicians must personalize insomnia treatment based on patient factors and use caution with all pharmacotherapies.
Area of Science:
- Sleep Medicine
- Pharmacology
- Behavioral Science
Background:
- Insomnia is a prevalent sleep disorder with significant clinical and economic impacts.
- Numerous treatment options exist for sleep onset and sleep maintenance difficulties.
- Understanding available therapies is crucial for effective insomnia management.
Purpose of the Study:
- To review and summarize current treatment options for insomnia.
- To provide an overview of both nonpharmacologic and pharmacologic interventions.
- To emphasize the importance of individualized treatment approaches.
Main Methods:
- Conducted a MEDLINE search for articles published between January 1996 and January 2006.
- Evaluated abstracts from recent professional meetings.
- Gathered information from the manufacturer of ramelteon.
Main Results:
- Nonpharmacologic treatments include stimulus control, sleep hygiene, sleep restriction, paradoxical intention, relaxation therapy, biofeedback, and cognitive behavioral therapy (CBT).
- Pharmacologic options include benzodiazepines, nonbenzodiazepine hypnotics, ramelteon (a melatonin receptor agonist), trazodone, and sedating antihistamines.
- Herbal and alternative preparations such as melatonin and valerian are also available.
Conclusions:
- Treatment selection requires careful consideration of patient-specific factors like age, medical history, and co-occurring drug use.
- The underlying cause of insomnia should guide treatment recommendations.
- Pharmacotherapy for insomnia should be used cautiously, at the minimum effective dose, and for the shortest necessary duration.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
CNS Depressants: Barbiturates and Benzodiazepines
Narcolepsy
